- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Mixture of two allogeneic human pancreatic cancer cell lines
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Mixture of two allogeneic human pancreatic cancer cell lines stably transduced with a retroviral vector encoding the murine alpha-(1,3)-galactosyltransferase gene
| EU orphan designation number: | EU/3/12/1048
|
| Active ingredient: | Mixture of two allogeneic human pancreatic cancer cell lines stably transduced with a retroviral vector encoding the murine alpha-(1,3)-galactosyltransferase gene |
| Indication: | Treatment of pancreatic cancer |
| Sponsor: | European Medical Advisory Services Limited
Choice House, 65 Knowl Piece, Wilbury Way, Hitchin, Hertfordshire SG4 0TY, United Kingdom |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 12/10/2012 | Orphan designation | EMA/OD/065/12 | (2012)7224 of 10/10/2012 |
CONTACT
EU links
Directorate General Health & Consumers